$16.13
-0.99-5.78%
al cierre: Nov 20, 4:00 PM EST
$16.69
0.563.47%
After hour: Nov 20, 6:19 PM EST

Structure Therapeutics (GPCR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 9, 2026 | $-0.66 | $-0.29 | -127.6 % |
| Q2 | Aug 6, 2026 | $-0.49 | $-0.38 | -28.9 % |
| Q1 | May 7, 2026 | $-0.35 | $-0.33 | -6.06 % |
| Q4 | Feb 26, 2026 | $-0.36 | $-0.36 | 0.00 % |
Quarterly Revenue (Billions)
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 9, 2026 | $0 | $50.00M | -100.0 % |
| Q1 | May 7, 2026 | $0 | $11.11M | -100.0 % |
| Q4 | Feb 26, 2026 | $0 | $200.00M | -100.0 % |
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.29 | $-0.38 | $-0.33 | $-0.36 |
| Actual | $-0.66 | $-0.49 | $-0.35 | $-0.36 |
| Surprise | -127.6% | -28.9% | -6.06% | 0.00% |
| Revenue | ||||
| Estimate | $50.0M | — | $11.1M | $200.0M |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | -100.0% | — | -100.0% | -100.0% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.33 | $-0.63 | $-0.60 | $-0.59 |
| Revenue | ||||
| Consensus | — | — | — | — |